Complete GLYC Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
GLYC DCF Analysis
GLYC (GlycoMimetics, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $74.9K | $10.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Revenue Growth % | - | -86.7% | -100.0% | -10.0% | -10.0% | -10.0% | -10.0% | -10.0% |
| EBIT | $-47.4M | $-39.3M | $-32.5M | $0 | $0 | $0 | $0 | $0 |
| EBIT Margin % | -63267.3% | -392752.9% | 0.0% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-35.6M | $-29.5M | $-24.4M | $0 | $0 | $0 | $0 | $0 |
| NOPAT Margin % | -47450.5% | -294564.7% | -Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% |
| Capex | $84.2K | $21.4K | $10.0K | $0 | $0 | $0 | $0 | $0 |
| Capex / Revenue % | 112.4% | 213.9% | Infinity% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Depreciation | $207.1K | $153.3K | $35.2K | $NaN | $NaN | $NaN | $NaN | $NaN |
| D&A / Revenue % | 276.5% | 1533.0% | Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% |
| Change in NWC | $-36.6M | $-4.9M | $-5.8B | $0 | $0 | $0 | $0 | $0 |
| NWC Change / Revenue % | -48844.4% | -48784.5% | -Infinity% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Unlevered FCF | $1.2M | $-24.4M | $5.8B | $NaN | $NaN | $NaN | $NaN | $NaN |
| UFCF % Chg. | - | -2194.1% | 23741.4% | NaN% | NaN% | NaN% | NaN% | NaN% |
| FCF / Revenue % | 1558.0% | -244461.1% | Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% |
| Discount Factor | - | - | - | 0.941 | 0.886 | 0.834 | 0.785 | 0.739 |
| Present Value of FCF | - | - | - | $NaN | $NaN | $NaN | $NaN | $NaN |
| Sum of PV of UFCF | - | - | - | $NaN | $NaN | $NaN | $NaN | $NaN |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 7.0% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.2% |
| Risk Free Rate | 4.46% |
| Market Risk Premium | 4.3% |
| Beta | 1.60 |
| Cost of Equity | 11.4% |
| Total Debt | $66.8M |
| Market Cap | $13.4M |
| Total Capital | $80.3M |
| Debt Weighting | 83.3% |
| Equity Weighting | 16.7% |
| WACC | 6.2% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $NaN |
| Terminal Value | $NaN |
| PV of Terminal Value | $NaN |
| Cumulative PV of UFCF | $NaN |
| Net Debt | $56.1M |
| Equity Value | $NaN |
| Shares Outstanding | 64.5M |
| Implied Share Price | $NaN |
| Current Share Price | $0 |
| Implied Upside/(Downside) | NaN% |
Valuation Summary
$NaN
Implied Price
$0.21
Current Price
NaN%
Upside/Downside
6.2%
WACC
GLYC Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-0.42
-303.5%
Peer Median: 1.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 1.2x
P/S Ratio
$0.00
-99.8%
Peer Median: 0.4x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for GLYC's business model and current situation.
Multiple Comparison
| Multiple | GLYC Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.5x | 1.0x | 1.0x | -149.1% | Undervalued |
| EV/EBITDA | Infinityx | 1.2x | 1.2x | Infinity% | Overvalued |
| P/S Ratio | 248.2x | 0.4x | 1.2x | 56537.2% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 2.9x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 20.8x | |
| $0.01B | 0.0x | 0.0x | 248.2x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 1.0x | 1.2x | 0.2x | |
| $0.01B | 0.0x | 0.0x | 0.4x |